Abstract--1. Flavonoids relaxed the contractions induced by noradrenaline, KCI or phorbol 12-myristate,13-acetate in rat aortic strips, the order of potency being: flavonols (quercetin, kaempferol, pentamethylquereetin)>flavones(luteolin, apigenin)>flavanols((+)-catechin, (-)-epicatechin) which correlates with the reported order of potency to inhibit protein kinase C.
INTRODUCTION
Flavonoids constitute a large group of low molecular weight polyphenolic compounds derived from plants which exhibit a broad spectrum of biological actions (Middleton, 1984; Cody et al., 1986; Pathak et al., 1991) . On the cardiovascular system flavonoids produced positive chronotropic and antiarrhythmic effects (Occhiuto et al., 1991; Laekeman et al., 1986) and most of them exhibited vasodilatory actions (Beretz et al., 1980; Ubeda et al., 1991; Ko et al., 1991; Duarte et al., 1993) . Although this vascular smooth muscle relaxation has been attributed to several mechanisms including decreased transmembrane 45Ca2+ uptake (Ko et al., 1991; Duarte et al., 1993) and an inhibitory effect on cAMP-and cGMPphosphodiesterase [PDE, Beretz et al. (1980 Beretz et al. ( , 1981 ] or protein kinase C (PKC) activity (Duarte et al., 1993) , the mechanism of action is far from clear. The present study was undertaken to evaluate the vasodilatory effects of seven flavonoids ( Fig. 1) and to investigate the possible relationships between their vasodilatory responses in different experimental conditions and the reported ability to inhibit PDE and PKC.
MATERIALS AND METHODS

Experimental procedure
Wistar rats (either sex, 250-300 g) were killed by a blow on the head. The descending thoracic aorta was rapidly *To whom all correspondence should be addressed. dissected and placed in a physiological saline solution (PSS) of the following composition (mM): NaC1 118, KCI 4.75, NaHCO 3 25, MgSO 4 1.2, CaCI 2 1.8, KH2PO 4 1.2 and glucose 11. After excess of fat and connective tissue was removed, the aortae were cut into helical strips (0.3 × 2 cm), mounted vertically under the basal tension of 1 g in 20 ml organ baths containing PSS and attached to forcedisplacement transducers (Letigraph 2000, Letica) to measure isometric contractile force as previously described (Zarzuelo et al., 1991; P~rez-Vizcaino et al., 1991) . The tissue bath was maintained at 37°C and bubbled with 95% 02-5% CO2 gas mixture. In some experiments the endothelium of the aorta was mechanically removed by gently rubbing the intimal surface of the vessel. The absence of endotbelium was confirmed by the absence of relaxing effects of acetylcholine (10-7-10-5M) in aortic strips previously contracted by 10-TM phenylephrine. Each preparation was allowed to equilibrate for at least 90 rain prior to initiation of experimental procedures and during this period the incubation media were changed every 20 min.
After equilibration the following experiments were performed: (I) aortic strips were contracted by single concentrations of noradrenaline (10-SM), KC1 (80mM) or phorbol 12-myristate 13-acetate (PMA, . When the contractile responses to either agonist were stable, flavonoids were added in progressively increasing cumulative concentrations (10-6-10 -~ M) at 30 min intervals since preliminary experiments demonstrated that this was the time needed to produce a steady-state relaxation. Only one flavonoid was tested in each aorta. (2) In another group of experiments strips were previously contracted by 10 -5 M noradrenaline. When the contractile response reached steady state tension, isoprenaline (10-7 M) or sodium nitroprusside (10 -s M) were added 20 min prior to the addition of the tested flavonoid. All the results were expressed as a percentage of the maximal control agonist-induced responses.
Drugs
The following drugs were used: quercetin and sodium nitroprusside (E. Merck, Darmstadt, Germany), kaempferol (Fluka Chemic AG, Buchs, Switzerland), apigenin, (+)-catechin, (-)-epicatechin, (-)-noradrenaline bitartrate, isoprenaline hydrochloride and PMA (Sigma Ltd Co., London). Luteolin was extracted from Daucus carota leaves and pentamethylquereetin was synthesized in our laboratory according to the method previously described by Mabry et al. (1970) . Drugs prepared in the laboratory showed identical spectral and chromatographic features to standard drugs. All flavonoids were initially dissolved in absolute ethanol and PMA in dimethyl sulfoxide (DMSO) respectively, to prepare a 10 -2 M stock solution. Further dilutions were made in PSS. The final ethanol or DMSO concentrations did not significantly affect the results. Ascorbic acid (10 -4 M) was added to each solution of noradrenaline and isoprenaline, made up freshly each day.
Statistics
Throughout the paper, values are expressed as mean + SEM and statistical analysis was performed with unpaired Student's t-test. The significance between control and experimental values was considered significant when P <0,05. Concentration-response curves were analyzed over the response range of 20-80% of the maximal contractile response to determine the concentration of the drug producing a 50% inhibition (IC50) using a linear regression analysis.
RESULTS
Effects on KCI-, noradrenaline-and PMA-induced contractions
Addition of single concentrations of high KC1 (80 mM), noradrenaline (10 -s M) or PMA (10 -7 M) produced a contractile response which averaged 514.6 _ 29.6 mg (n = 45), 548.7 __ 24.4 mg (n = 50) and 424.9 + 20.3 mg (n = 45), respectively. At concentrations > 10 -6 M, all flavonoids tested produced a concentration-dependent inhibition of the contractile responses induced by high KCI (Fig. 2) , noradrenaline (Fig. 3) or PMA (Fig. 4) . The IC50 values against the contractions induced by these three agonists are compared in Table 1 . It can be observed that flavonols, i.e. quercetin and kaempferol, were the most potent drugs against the contractile responses induced by the three vasoconstrictors, whereas flavanols like (+)-catechin and (-)-epicatechin were the least effective agents. Flavones (i.e. apigenin and luteolin) have an intermediate potency between flavonols and flavanols. With the exception of apigenin, all the flavonoids were significantly more potent to inhibit noradrenaline-than KCl-contraction. Kaempferol and apigenin were at least two times more potent (P < 0.05) to inhibit noradrenaline-than PMA-induced contractions. In contrast, luteolin was less potent (P < 0.05) to inhibit noradrenaline-than PMA-induced contractions. Pentamethylation of quercetin reduced its vasodilatory activity 2-to 3-fold against noradrenaline-and KCI-, and 10-fold against PMA-induced contractions. No stereoselectivity was observed within the two enantiomers (+)-catechin and (-)-epicatechin. The relaxant effects of the flavonoids tested on noradrenaline-induced contractions were not altered by mechanical removal of endothelium (not shown).
Effect of the pretreatment with isoprenaline or sodium nitroprusside
Nucleotide PDE inhibitors potentiate the relaxant effects of isoprenaline and sodium nitroprusside (Lorenz and Wells, 1983; Duarte et al., 1992) . In the present experiments isoprenaline (10-7 M) alone, produced a weak relaxation of noradrenaline-induced contractions (5.2_ 1.3%, n =42) and significantly potentiated (P < 0.05) the relaxant effects of kaempferol and luteolin on these contractile responses (Table 1) . Sodium nitroprusside (10-aM) produced a relaxation averaging 22.3 + 1.9% (n = 42) of the maximal contractile response induced by noradrenaline. Moreover, pretreatment with this nitrovasodilator agent potentiated (P < 0.05) the relaxant effects of kaempferol, apigenin and pentamethylquercetin on noradrenaline-induced contractions (Table 1) .
DISCUSSION
The present paper describes the vasodilatory effects of seven flavonoids in rat aortic strips on the contractions induced by noradrenaline, KCI and the phorbol ester derivative PMA, as well as the interactions of these flavonoids with isoprenaline and sodium nitroprusside.
From the present results the following structureactivity relationships can be inferred: (a) the lower activity exhibited by flavanols against the contractions induced by any of the agonists tested, suggests that the 4-carbonyl group is required for the vasodilatory activity. According to Ferriola et al. (1989) , this structural feature is also required for the inhibitory effects on PKC in rat brain. (b) The absence or methylation of the group of the hydroxyl group in position 3' accounts for a lower vasodilatory potency and also decreases the potency to inhibit PKC activity (Ferriola et al., 1989) . In contrast, the 530 _+ I00 540 ± 120 380 ± 90 > 1000 > 1000 Data are mean _+ SEM, n = 6. *P < 0.05 and **P < 0.01 compared to NA. lack of the 3'-hydroxyl group is related with a potentiation of the effects in the presence of sodium nitroprusside suggesting an inhibited cGMP PDE activity. However, from the present results, no relation could be found between the potentiation of the relaxant effects by isoprenaline and the chemical structure of the flavonoid.
PKC has been proposed to play a key role in maintenance of tonic contractions of vascular smooth muscle (Rasmussen et al., 1987) although the mechanism involved is not well defined (Andrea and Walsh, 1992) . In Ca-free solution, phorbol esters activate PKC and induce a slowly developing sustained contraction in rat aorta without changing [ Ca2+ ]i or myosin light chain phosphorilation (Sato et al., 1992) . Flavonoids inhibit PKC, being competitive inhibitors with respect to ATP binding, and noncompetitive with respect to protein substrate, this inhibition was independent of Ca 2+, phospholipid and enzyme activator (Ferriola et al., 1989; Gschwendt et al., 1983) . However, these drugs are rather unspecific since they also inhibit a number of protein kinases such as cAMP-dependent protein kinase, myosin light chain kinase and phosphatidylinositoi-4-phosphate kinase (Cochet and Chambaz, 1986; Hagiwara et al., 1988) . The inhibitory effect of PKC has been implicated in the inhibition of tumor promotion (Kato et al., 1983; Hofmann et al., 1988) or histamine release from human basophils (Middleton and Drzewiecki, 1984; Middleton et al., 1987) caused by flavonoids. In the present paper all flavonoids tested relaxed, in a concentration-dependent manner, the sustained contraction induced by PMA. Furthermore, a good correlation was found between the potency to relax previously contracted aortae, particularly when activated by PMA, and the potency to inhibit PKC from rat brain reported by Ferriola et al. (1989) . In addition, PKC inhibitors such as staurosporin and H7 also inhibit the contractions induced by KCI or noradrenaline in arterial vascular smooth muscle (Kageyama et al., 1991; Merkel et al., 1991) . Therefore, it seems likely that the vasodilatory effects of flavonoids found in this study can be attributed to inhibition of PKC. However, measurements of PKC activity in vascular smooth muscle would be needed to confirm this possibility.
KCl-induced contractions are the result of an increased Ca 2+ influx through voltage-stimulated type-L Ca 2÷ channels (Bolton, 1979) , and are specifically inhibited by Ca 2+ antagonists (Godfraind et al., 1986) . Thus, the inhibitory effects of flavonoids on the contractile responses induced by high KCI could be attributed, at least partly, to a blockade of Ca 2÷ entry through voltage-stimulated Ca 2+ channels. In fact, quercetin inhibited the contractions induced by increases in extracellular Ca 2+ in KCl-depolarized aortae and suppressed the spontaneous myogenic contractions recorded in portal veins (Duarte et al., 1993) and apigenin and khellin reduced the high KCl-stimulated 45Ca2+ influx in rat aorta (Ko et al., 1991; Ubeda et al., 1991) .
Cyclic nucleotides can dilate vascular smooth muscle, either by phosphorylation of myosin light chain kinase or by acting in other ways to reduce free cytosolic calcium (Adelstein and Eistenberg, 1980; Kamm and Stull, 1985; Hardman, 1984) . Flavonoids and biflavonoids produce an inhibitory action on cyclic nucleotide PDEs (Beretz et al., 1978; Nikaido et al., 1982) which may be responsible for the inhibitory effect on platelet aggregation (Beretz et al., 1981) and vascular smooth muscle relaxation (Beretz et al., 1980) . In the present paper, the ability of isoprenaline or sodium nitroprusside to potentiate the relaxant effects of flavonoids has been used as a functional test to investigate the inhibitory effects of these drugs on cAMP or cGMP PDEs, respectively. Pretreatment with isoprenaline produced a mild, but significant potentiation of the vasodilatory effects of kaempferol and luteolin, which suggests a possible role of cAMP on their inhibitory effects on the noradrenalineinduced contractions. Vasorelaxation induced by kaempferol, apigenin and pentamethyiquercetin was potentiated by pretreatment with sodium nitroprusside. This implies that their relaxing effects could be partly related to increased levels of cGMP.
Quercetin has been reported to interact with the CaZ+-calmodulin complex (Nishino et al., 1984) . In rat aorta calmodulin antagonists inhibit PMA-induced contractions when added before the agonist but, in contrast to flavonoids, they produce a weak relaxation when applied during the plateau of PMAinduced contractions and had almost no relaxant effect on high K-and NA-induced contractions (Chuprun et al., 1991) . Thus, the vasodilator effect of quercetin can not be attributed to an inhibition of calmodulin activity. Another possible mechanism involved in the relaxant effects of flavonoids include an inhibition of Ca 2+ uptake into the sarcoplasmic reticulum, an effect described in skeletal muscle fibres (Shoshan et al., 1980) . However, this possibility can be ruled out since quercetin inhibited PMA-induced contraction in Ca-free PSS containing EDTA after depletion of noradrenaline-sensitive intracellular Ca :+ stores with the same potency as it did in the presence of Ca 2+ (Duarte et al., 1993) .
In conclusion, in isolated rat aorta, flavonoids produced vasodilatory effects that seem to be mainly related to the inhibition of PKC. An inhibitory effect on cyclic nucleotide PDE and Ca 2+ uptake may also contribute to the vasodilatory action of these drugs.
SUMMARY
The present paper describes the vasodilatory effects of seven flavonoids on the contractions induced by noradrenaline, KC1 and the phorbol ester derivative PMA in rat aortic strips. The ability of isoprenaline or sodium nitroprusside to potentiate the relaxant effects of flavonoids on noradrenaline-induced contraction has been used as a functional test to investigate the inhibitory effects of these drugs on cAMP or cGMP PDEs, respectively. The presence of a 4-carbonyl or a Y-hydroxyl group in the molecule increased the vasodilatory potencies which correlates with the reported potency to inhibit PKC activity. In contrast, the lack of the 3'-hydroxyl group is related with a potentiation of the effects in the presence of sodium nitroprusside suggesting an inhibited cGMP PDE activity. Mechanical removal of endothelium did not modify the relaxant effects of the flavonoids. It is concluded that the main vasodilatory mechanism of flavonoids seems to be the inhibition of PKC. Inhibition of cyclic nucleotide PDEs or decreased Ca 2÷ uptake may also contribute to their vasodilatory effects.
